A client is teaching a client who has a new prescription for hydrochlorothiazide for management of hypertension. Which of the following Instructions should the nurse include?

A) "I should limit my fluid intake while taking this medication":
This statement is incorrect. Furosemide is a loop diuretic that increases urine production to reduce fluid overload in conditions like heart failure or edema. It is essential for clients taking furosemide to maintain adequate hydration to prevent dehydration. Therefore, the client should not limit their fluid intake while taking this medication.

B) "My blood pressure will increase while I am taking this medication":
This statement is incorrect. Furosemide is primarily used to reduce blood pressure by promoting diuresis and reducing fluid volume. Therefore, it is unlikely that blood pressure would increase while taking this medication.

C) "I should take this medication in the morning rather than at night":
This is the correct answer. Furosemide is usually taken in the morning to prevent nocturia (excessive urination at night), as it can increase urinary frequency. Taking it earlier in the day allows for better fluid balance during waking hours and reduces the need to wake up frequently during the night to urinate.

D) "I should eat a diet low in potassium while taking this medication":
This statement is incorrect. Furosemide can cause potassium depletion as a side effect, so clients may be advised to consume potassium-rich foods or supplements unless contraindicated due to other medical conditions. However, it is not necessary to eat a diet low in potassium while taking furosemide unless specifically instructed by a healthcare provider.

A) Loss of protective respiratory mechanisms due to prolonged irritation or damage:
Individuals with COPD often experience a progressive loss of protective respiratory mechanisms over time. Chronic exposure to irritants such as cigarette smoke leads to inflammation, structural changes in the airways, and destruction of lung tissue, impairing the body's ability to clear mucus, trap foreign particles, and maintain normal lung function. This loss of protective mechanisms contributes to the hallmark symptoms of COPD, including airflow limitation, chronic cough, and increased susceptibility to respiratory infections.

B) Localized swelling and inflammation within the lungs:
While inflammation is a hallmark feature of COPD, it typically manifests as widespread inflammation throughout the lungs rather than localized swelling. In COPD, chronic exposure to irritants leads to a systemic inflammatory response that affects the entire respiratory tract, including the bronchi and alveoli. This inflammation contributes to airway obstruction, mucus hypersecretion, and the development of respiratory symptoms.

C) An acute viral infection of the respiratory tract:
While individuals with COPD are at increased risk of respiratory infections, including viral infections such as influenza and respiratory syncytial virus (RSV), COPD itself is a chronic, progressive respiratory condition characterized by persistent airflow limitation. Acute viral infections may exacerbate COPD symptoms and lead to worsening respiratory function, but they are not inherent features of the disease itself.

D) Inflammation and swelling of the sinus membranes over a prolonged period:
Sinus inflammation and swelling, known as sinusitis, are not typically considered primary features of COPD. While individuals with COPD may experience comorbid conditions such as chronic rhinosinusitis, which can contribute to respiratory symptoms and exacerbations, sinus inflammation is not a defining characteristic of the disease.